QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
New cost-effectiveness evidence on nirmatrelvir/ritonavir in the progression of COVID-19
Not only can SARS-CoV-2 infection result in immediate respiratory symptoms, but it can also lead to post-acute COVID-19 syndrome (PACS), lasting several months after recovery. At this year’s ISPOR in Copenhagen, Quantify Research’s own Martina Aldvén and Marcelina Kądziela, in collaboration with Pfizer, presented a poster on the cost-effectiveness of nirmatrelvir/ritonavir (NV/r) compared to no anti-viral treatment in Swedish […]
Happy New Year!
Happy New Year! We’d like to wish you a fantastic start to 2024.
The Quantify Research team has returned, feeling refreshed from our holiday break. It’s great to be back in the swing of things, helping our clients supply innovative medicines to patients.
Should you need any assistance or have any inquiries, feel free to contact us at info@quantifyresearch.com. Also, visit our website at […]
Merry Christmas!
The whole Quantify Research team wishes you a joyous holiday season, whatever you celebrate and wherever you are.
🎄we are in the festive spirit at Quantify´s Stockholm HQ 🎄
At Quantify Research we never miss a good opportunity to get together and preferably also eat cake.
Yesterday’s fika coincided with Lucia. This Swedish celebration with its multifaceted roots in Italian sainthood, medieval carnivals and West Coast tradition offers a welcome opportunity for us all to get together and sing Christmas hymns.
With thanks to The Fun Task Force for also organizing our Christmas jumper […]